Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
| Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
| Autore | Viseras César |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (202 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
aeroperl
antimicrobial properties bioactive elements bioadhesion biocompatibility chitosan chondroitin sulfate clay minerals cyclodextrins cytotoxicity dissolution improvement dissolution rate drug electrospinning element mobility fibroblast fibroblasts proliferation Franz cell glyburide glycosaminoglycans halloysite halloysite nanotube hazardous element heavy metal hybrid hydrochlorothiazide hydrogel hydrogel film hydrotalcite immune response in vitro dissolution tests ketoprofen liquisolid technique mesoporous clay methotrexate montmorillonite n/a nanoclay Neusilin organic solvents osteosarcoma palygorksite palygorskite photostability praziquantel proliferation scaffolds sepiolite spring water surface modification tablet targeted drug delivery toxicity wound healing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557129803321 |
Viseras César
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Killing Cancer : Discovery and Selection of New Target Molecules
| Killing Cancer : Discovery and Selection of New Target Molecules |
| Autore | Kallunki Tuula |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (302 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
3D growth
ABCG2 AF1Q anoikis ATP-binding cassette transporter ATP6V0a3 ATR pathway autophagy BRCA1 BRCA2 breast cancer resistance protein (BCRP) breast cancer stem cells C2 domain cancer cancer metabolism cancer therapy CD domain chondroitin sulfate colorectal cancer dexamethasone disulfiram DNA damage drug efflux pumps dysferlin EMT epithelial-mesenchymal transition ERK1 ERK2 esophageal cancer ferlin glucocorticoids IL-8 immunotherapy inflammation invasion kinase inhibitors lysosome lysosome-mediated invasion mammosphere MAPK kinase matrix degradation metabolism microgravity microsatellite instability migration MLLT11 mTOR in immunotherapy mTOR inhibitors mTOR signaling mTORC1 mTORC2 multidrug resistance in cancer myoferlin MZF1 n/a NF-κB NPL4 nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB) nutrient metabolism oncofetal chondroitin sulfate otoferlin PAK4 PDAC pediatric cancer pH-regulation phosphorylation plasma membrane prognosis proliferation pyrazolo-pyrimidine derivative rapalogs replication stress Rolled SCH772984 SCO-201 sevenmaker solid tumors space environment STAT sulconazole SUMOylation target targeted cancer therapy TCIRG1 thyroid cancer transcription factor VAR2 VRT-11E WNT zinc finger |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Killing Cancer |
| Record Nr. | UNINA-9910557648103321 |
Kallunki Tuula
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Looking Forward To The Future of Heparin : : New Sources, Developments and Applications / / Giangiacomo Torri, Jawed Fareed
| Looking Forward To The Future of Heparin : : New Sources, Developments and Applications / / Giangiacomo Torri, Jawed Fareed |
| Autore | Torri Giangiacomo |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2018 |
| Descrizione fisica | 1 electronic resource (282 p.) |
| Soggetto topico | Chemistry |
| Soggetto non controllato |
alginate
edema Heparin Red solid lipid nanoparticles Fe3O4·DA-BSA/HA dermatan sulfate sulfated alginate porcine heparin theranostics low-molecular-weight heparin Arixtra® biomaterials hepcidin ovarian cancer iron oxide nanoparticles heparin-induced thrombocytopenia bone morphogenetic protein (BMP) hyaluronic acid (HA) crude heparin platelets resistance sclerostin LMWH gremlin low molecular weight heparin (LMWH) low molecular weight glycosaminoglycans human plasma single crystal X-ray structure iron homeostasis noggin super paramagnetic iron oxide nanoparticles (SPION) manufacturing methods paclitaxel (PTX) brain injury bovine heparin inflammation qNMR antithrombin reference standard quantitative NMR enoxaparin danaparoid sodium NMR GDNF orthogonal multi-analytical methods ternary complex heparan sulphate serglycin bovine serum albumin (BSA) HSQC recombinant expression heparin heparin oligosaccharides functional assay BMP antagonists intestinal lymphatic absorption size exclusion chromatography heparin coating diagnosis bioreactor anemia proteoglycan heparin process PCA chemometric fluorescent probe pharmacopeia affinity chromatography component quantitative analysis Fondaparinux sodium perylene diimide dyes thrombin inhibition extended physicochemical characterization cisplatin glycosaminoglycans TGF-? chondroitin sulfate dalteparin sequence and compositional investigations molecular weight magnetic resonance imaging (MRI) industrial LC-MS iduronic acid conformation heparan sulfate growth and differentiation factor (GDF) assay subarachnoid hemorrhage |
| ISBN |
9783038429500
3038429503 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346841803321 |
Torri Giangiacomo
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2018 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||